Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Development of an After-School Day Treatment Program for Children with Severe Emotional/Behavioral Disturbances.

Row KR, Kim BN, Kim T, Park YM, Hong KM.

Community Ment Health J. 2020 Feb 1. doi: 10.1007/s10597-020-00564-0. [Epub ahead of print]

PMID:
32008129
2.

False-negative errors in next-generation sequencing contribute substantially to inconsistency of mutation databases.

Kim YH, Song Y, Kim JK, Kim TM, Sim HW, Kim HL, Jang H, Kim YW, Hong KM.

PLoS One. 2019 Sep 12;14(9):e0222535. doi: 10.1371/journal.pone.0222535. eCollection 2019.

3.

Validation of a risk screening tool for pediatric type 1 diabetes patients: a predictor of increased acute health care utilization.

Glick BA, Hong KMC, Buckingham D, Moore-Clingenpeel M, Salvator A, Kamboj MK.

J Pediatr Endocrinol Metab. 2019 Oct 25;32(10):1155-1162. doi: 10.1515/jpem-2019-0156.

PMID:
31490774
4.

FAK-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast Cancer.

Kim YH, Kim HK, Kim HY, Gawk H, Bae SH, Sim HW, Kang EK, Seoh JY, Jang H, Hong KM.

Cancers (Basel). 2019 Sep 2;11(9). pii: E1288. doi: 10.3390/cancers11091288.

5.

Monitoring circulating tumor DNA by analyzing personalized cancer-specific rearrangements to detect recurrence in gastric cancer.

Kim YW, Kim YH, Song Y, Kim HS, Sim HW, Poojan S, Eom BW, Kook MC, Joo J, Hong KM.

Exp Mol Med. 2019 Aug 8;51(8):93. doi: 10.1038/s12276-019-0292-5.

6.

Determination of Protein Expression Level in Cultured Cells by Immunocytochemistry on Paraffin-embedded Cell Blocks.

Poojan S, Kim HS, Yoon JW, Sim HW, Hong KM.

J Vis Exp. 2018 May 20;(135). doi: 10.3791/57369.

7.

Morbid obesity: potential effects of hormonal contraception.

Stanczyk FZ, Burke AE, Hong KM, Archer DF.

Contraception. 2018 Sep;98(3):174-180. doi: 10.1016/j.contraception.2018.05.008. Epub 2018 May 16. No abstract available.

PMID:
29777662
8.

Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF.

Ko A, Han SY, Choi CH, Cho H, Lee MS, Kim SY, Song JS, Hong KM, Lee HW, Hewitt SM, Chung JY, Song J.

Cell Death Differ. 2018 Jun;25(6):1050-1062. doi: 10.1038/s41418-018-0072-0. Epub 2018 Feb 22.

9.

Identifying depressive symptoms among diabetes type and the impact on hemoglobin A1c.

Glick BA, Hong KMC, Obrynba K, Kamboj MK, Hoffman RP.

J Pediatr Endocrinol Metab. 2018 Jan 26;31(1):39-44. doi: 10.1515/jpem-2017-0241.

PMID:
29303779
10.
11.

CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer.

Sim SH, Bae CD, Kwon Y, Hwang HL, Poojan S, Hong HI, Kim K, Kang SH, Kim HS, Um TH, Park IH, Lee KS, Jung SY, Lee S, Kang HS, Lee ES, Kim MK, Hong KM, Ro J.

PLoS One. 2017 Aug 3;12(8):e0182107. doi: 10.1371/journal.pone.0182107. eCollection 2017.

12.

CD3Z hypermethylation is associated with severe clinical manifestations in systemic lupus erythematosus and reduces CD3ΞΆ-chain expression in T cells.

Hong KM, Kim HK, Park SY, Poojan S, Kim MK, Sung J, Tsao BP, Grossman JM, Rullo OJ, Woo JM, McCurdy DK, Rider LG, Miller FW, Song YW.

Rheumatology (Oxford). 2017 Mar 1;56(3):467-476. doi: 10.1093/rheumatology/kew405.

13.

Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.

Lee JS, Kang JH, Lee SH, Hong D, Son J, Hong KM, Song J, Kim SY.

Cell Death Dis. 2016 Dec 8;7(12):e2511. doi: 10.1038/cddis.2016.404.

14.

Aldehyde dehydrogenase is used by cancer cells for energy metabolism.

Kang JH, Lee SH, Hong D, Lee JS, Ahn HS, Ahn JH, Seong TW, Lee CH, Jang H, Hong KM, Lee C, Lee JH, Kim SY.

Exp Mol Med. 2016 Nov 25;48(11):e272. doi: 10.1038/emm.2016.103.

15.

Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.

Kang JH, Lee SH, Lee JS, Nam B, Seong TW, Son J, Jang H, Hong KM, Lee C, Kim SY.

Oncotarget. 2016 Aug 2;7(31):49397-49410. doi: 10.18632/oncotarget.10354.

16.

Clinical implications of proliferation activity in T1 or T2 male gastric cancer patients.

Kim YW, Eom BW, Kook MC, Kim HS, Kim MK, Hwang HL, Chandra V, Poojan S, Song Y, Koh JS, Bae CD, Ro J, Hong KM.

Exp Mol Med. 2015 Nov 6;47:e193. doi: 10.1038/emm.2015.79.

17.

Immunohistochemical localization of LLC1 in human tissues and its limited expression in non-small cell lung cancer.

Chandra V, Choi YB, Hwang HL, Lee JH, Park SY, Kim HK, Poojan S, Koh JS, Kim HS, Hong KM.

Histol Histopathol. 2015 Sep;30(9):1111-20. doi: 10.14670/HH-11-608. Epub 2015 Mar 18.

PMID:
25786037
18.

The association of uterine cervical microbiota with an increased risk for cervical intraepithelial neoplasia in Korea.

Oh HY, Kim BS, Seo SS, Kong JS, Lee JK, Park SY, Hong KM, Kim HK, Kim MK.

Clin Microbiol Infect. 2015 Jul;21(7):674.e1-9. doi: 10.1016/j.cmi.2015.02.026. Epub 2015 Mar 6.

19.

Effects of deranged metabolism on epigenetic changes in cancer.

Chandra V, Hong KM.

Arch Pharm Res. 2015 Mar;38(3):321-37. doi: 10.1007/s12272-015-0561-3. Epub 2015 Jan 29. Review.

PMID:
25628247
20.

Targeted next-generation sequencing at copy-number breakpoints for personalized analysis of rearranged ends in solid tumors.

Kim HK, Park WC, Lee KM, Hwang HL, Park SY, Sorn S, Chandra V, Kim KG, Yoon WB, Bae JS, Shin HD, Shin JY, Seoh JY, Kim JI, Hong KM.

PLoS One. 2014 Jun 17;9(6):e100089. doi: 10.1371/journal.pone.0100089. eCollection 2014.

21.

Chromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancer.

Kim HS, Koh JS, Choi YB, Ro J, Kim HK, Kim MK, Nam BH, Kim KT, Chandra V, Seol HS, Noh WC, Kim EK, Park J, Bae CD, Hong KM.

PLoS One. 2014 Jun 2;9(6):e98160. doi: 10.1371/journal.pone.0098160. eCollection 2014.

22.

Association of polymorphisms and haplotypes in the insulin-like growth factor 1 receptor (IGF1R) gene with the risk of breast cancer in Korean women.

Kang HS, Ahn SH, Mishra SK, Hong KM, Lee ES, Shin KH, Ro J, Lee KS, Kim MK.

PLoS One. 2014 Jan 2;9(1):e84532. doi: 10.1371/journal.pone.0084532. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e91218.

23.

Down-regulation of lipid raft-associated onco-proteins via cholesterol-dependent lipid raft internalization in docosahexaenoic acid-induced apoptosis.

Lee EJ, Yun UJ, Koo KH, Sung JY, Shim J, Ye SK, Hong KM, Kim YN.

Biochim Biophys Acta. 2014 Jan;1841(1):190-203. doi: 10.1016/j.bbalip.2013.10.006. Epub 2013 Oct 11. Erratum in: Biochim Biophys Acta. 2014 Dec;1841(12):1647.

PMID:
24120917
24.

Simple and versatile molecular method of copy-number measurement using cloned competitors.

Kim HK, Hwang HL, Park SY, Lee KM, Park WC, Kim HS, Um TH, Hong YJ, Lee JK, Joo SY, Seoh JY, Song YW, Kim SY, Kim YN, Hong KM.

PLoS One. 2013 Jul 30;8(7):e69414. doi: 10.1371/journal.pone.0069414. Print 2013.

25.

p53 acetylation enhances Taxol-induced apoptosis in human cancer cells.

Kim JH, Yoon EK, Chung HJ, Park SY, Hong KM, Lee CH, Lee YS, Choi K, Yang Y, Kim K, Kim IH.

Apoptosis. 2013 Jan;18(1):110-20. doi: 10.1007/s10495-012-0772-8.

PMID:
23161364
26.

An in vivo C. elegans model system for screening EGFR-inhibiting anti-cancer drugs.

Bae YK, Sung JY, Kim YN, Kim S, Hong KM, Kim HT, Choi MS, Kwon JY, Shim J.

PLoS One. 2012;7(9):e42441. doi: 10.1371/journal.pone.0042441. Epub 2012 Sep 5.

27.

Cyclin A regulates a cell-cycle-dependent expression of CKAP2 through phosphorylation of Sp1.

Kang DS, Hong KM, Park J, Bae CD.

Biochem Biophys Res Commun. 2012 Apr 20;420(4):822-7. doi: 10.1016/j.bbrc.2012.03.081. Epub 2012 Mar 23.

PMID:
22465120
28.

Condensed chromatin staining of CKAP2 as surrogate marker for mitotic figures.

Kim HS, Choi YB, Lee JH, Park SY, Kim HK, Koh JS, Yi SY, Kim KT, Hong KU, Park J, Bae CD, Hong KM.

J Cancer Res Clin Oncol. 2012 Jan;138(1):95-102. doi: 10.1007/s00432-011-1053-6. Epub 2011 Oct 22.

PMID:
22020800
29.

Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer.

Choi CM, Jang SJ, Park SY, Choi YB, Jeong JH, Kim DS, Kim HK, Park KS, Nam BH, Kim HR; Korean Thoracic Oncology Research Group (KTORG), Kim SY, Hong KM.

Mol Cancer. 2011 Sep 24;10:119. doi: 10.1186/1476-4598-10-119.

30.

Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking.

Kim DS, Choi YB, Han BG, Park SY, Jeon Y, Kim DH, Ahn ER, Shin JE, Lee BI, Lee H, Hong KM, Kim SY.

Oncogene. 2011 Dec 1;30(48):4780-90. doi: 10.1038/onc.2011.183. Epub 2011 May 30.

PMID:
21625219
31.

Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer.

Gill RK, Yang SH, Meerzaman D, Mechanic LE, Bowman ED, Jeon HS, Roy Chowdhuri S, Shakoori A, Dracheva T, Hong KM, Fukuoka J, Zhang JH, Harris CC, Jen J.

Oncogene. 2011 Sep 1;30(35):3784-91. doi: 10.1038/onc.2011.98. Epub 2011 May 2.

32.

Bioimaging for the monitoring of the in vivo distribution of infused mesenchymal stem cells in a mouse model of the graft-versus-host reaction.

Joo SY, Cho KA, Jung YJ, Kim HS, Park SY, Choi YB, Hong KM, Woo SY, Seoh JY, Ryu KH.

Cell Biol Int. 2011 Apr;35(4):417-21. doi: 10.1042/CBI20100563.

PMID:
21062262
33.

Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner.

Joo SY, Cho KA, Jung YJ, Kim HS, Park SY, Choi YB, Hong KM, Woo SY, Seoh JY, Cho SJ, Ryu KH.

Cytotherapy. 2010 May;12(3):361-70. doi: 10.3109/14653240903502712.

PMID:
20078382
34.

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.

Park KS, Kim HK, Lee JH, Choi YB, Park SY, Yang SH, Kim SY, Hong KM.

J Cancer Res Clin Oncol. 2010 Apr;136(4):493-502. doi: 10.1007/s00432-009-0681-6. Epub 2009 Sep 18.

PMID:
19763620
35.

Cdk1-cyclin B1-mediated phosphorylation of tumor-associated microtubule-associated protein/cytoskeleton-associated protein 2 in mitosis.

Hong KU, Kim HJ, Kim HS, Seong YS, Hong KM, Bae CD, Park J.

J Biol Chem. 2009 Jun 12;284(24):16501-12. doi: 10.1074/jbc.M900257200. Epub 2009 Apr 15.

36.

Glycyrrhizin prevents 7-ketocholesterol toxicity against differentiated PC12 cells by suppressing mitochondrial membrane permeability change.

Kim DE, Youn YC, Kim YK, Hong KM, Lee CS.

Neurochem Res. 2009 Aug;34(8):1433-42. doi: 10.1007/s11064-009-9930-y. Epub 2009 Feb 18.

PMID:
19224363
37.

Transient phosphorylation of tumor associated microtubule associated protein (TMAP)/cytoskeleton associated protein 2 (CKAP2) at Thr-596 during early phases of mitosis.

Hong KU, Choi YB, Lee JH, Kim HJ, Kwon HR, Seong YS, Kim HT, Park J, Bae CD, Hong KM.

Exp Mol Med. 2008 Aug 31;40(4):377-86.

38.

Predisposition of genetic disease by modestly decreased expression of GCH1 mutant allele.

Kim YS, Choi YB, Lee JH, Yang SH, Cho JH, Shin CH, Lee SD, Paik MK, Hong KM.

Exp Mol Med. 2008 Jun 30;40(3):271-5.

39.

Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma.

Hong KM, Belperio JA, Keane MP, Burdick MD, Strieter RM.

J Biol Chem. 2007 Aug 3;282(31):22910-20. Epub 2007 Jun 7.

40.

Mild encephalopathy with reversible lesion in the splenium of the corpus callosum and bilateral frontal white matter.

Cho JS, Ha SW, Han YS, Park SE, Hong KM, Han JH, Cho EK, Kim DE, Kim JG.

J Clin Neurol. 2007 Mar;3(1):53-6. doi: 10.3988/jcn.2007.3.1.53. Epub 2007 Mar 20.

41.

Inactivation of LLC1 gene in nonsmall cell lung cancer.

Hong KM, Yang SH, Chowdhuri SR, Player A, Hames M, Fukuoka J, Meerzaman D, Dracheva T, Sun Z, Yang P, Jen J.

Int J Cancer. 2007 Jun 1;120(11):2353-8.

42.

Characterization of human fibrocytes as circulating adipocyte progenitors and the formation of human adipose tissue in SCID mice.

Hong KM, Burdick MD, Phillips RJ, Heber D, Strieter RM.

FASEB J. 2005 Dec;19(14):2029-31. Epub 2005 Sep 27.

PMID:
16188961
43.

Increased lysine N-methylation of a 23-kDa protein during hepatic regeneration.

Choi YB, Ko MH, Shin CH, Kim KS, Hong KM, Paik MK, Park DE.

Exp Mol Med. 2005 Jun 30;37(3):155-60.

PMID:
16000868
44.

Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer.

Yang SH, Mechanic LE, Yang P, Landi MT, Bowman ED, Wampfler J, Meerzaman D, Hong KM, Mann F, Dracheva T, Fukuoka J, Travis W, Caporaso NE, Harris CC, Jen J.

Clin Cancer Res. 2005 Mar 15;11(6):2106-10. Erratum in: Clin Cancer Res. 2005 Nov 1;11(21):7960-1.

45.

Semiautomatic detection of DNA methylation at CpG islands.

Hong KM, Yang SH, Guo M, Herman JG, Jen J.

Biotechniques. 2005 Mar;38(3):354, 356, 358. No abstract available.

46.

Allele frequencies of 10 STR loci in Koreans.

Shin CH, Jang P, Hong KM, Paik MK.

Forensic Sci Int. 2004 Feb 10;140(1):133-5.

PMID:
15013178
47.
48.

Detection and typing of HSV-1, HSV-2, CMV and EBV by quadruplex PCR.

Shin CH, Park GS, Hong KM, Paik MK.

Yonsei Med J. 2003 Dec 30;44(6):1001-7.

50.

Identification of TDE2 gene and its expression in non-small cell lung cancer.

Player A, Gillespie J, Fujii T, Fukuoka J, Dracheva T, Meerzaman D, Hong KM, Curran J, Attoh G, Travis W, Jen J.

Int J Cancer. 2003 Nov 1;107(2):238-43.

Supplemental Content

Support Center